title: Incompatibility - Neonatal Intensive Care Drug Manual
text: |
  Neonatal Intensive Care Drug Manual
  |
  bet | 225/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Incompatibility
  |
  Fluids: No information. Variable compatibility with parenteral nutrition solutions.
  Y-site: Atracurium, azithromycin, benztropine, buprenorphine, caffeine citrate, caspofungin, chlorpromazine, ciprofloxacin, dolasetron, droperidol, eptifibatide, erythromycin, esmolol, filgrastim, fluconazole, gentamicin, glycopyrrolate, haloperidol lactate, hyaluronidase, hydralazine, ketamine, labetalol, metaraminol, metoclopramide, midazolam, milrinone, moxifloxacin, mycophenolate mofetil, ondansetron, pancuronium, pentamidine, pethidine, phentolamine, phenylephrine, promethazine, protamine, quinine, rocuronium, vancomycin, vasopressin, vecuronium, verapamil.
  |
  Stability
  |
  Do not use if solution is discoloured.
  Diluted IV solution: Stable for 24 hours at 2−25°C (preferred storage is 2-8°C).
  Oral solution:
  Commercial preparation “Lasix”- Discard 8 weeks after opening.
  Compounded suspension – 14 day expiry.
  |
  Storage
  |
  Vial: Store below 25°C. Protect from light.
  Occasionally crystal deposits may be seen when ampoules are stored at low temperatures. Dissolve crystals by warming to 40°C and injection may be used. Discard solutions that are yellow.
  Oral solution:
  Commercial preparation - store below 25°C
  Compounded suspension – refrigerated at 2-8°C
  |
  |
  |
  | |